McClain Scott, Jones Wendelyn, He Xiaoyun, Ladics Gregory, Bartholomaeus Andrew, Raybould Alan, Lutter Petra, Xu Haibin, Wang Xue
Syngenta Crop Protection, LLC 3054 E. Cornwallis Rd.Research Triangle Park, NC 27709, USA. Email:
Zhonghua Yu Fang Yi Xue Za Zhi. 2015 Jan;49(1):78-87.
Genetically modified (GM) crops were first introduced to farmers in 1995 with the intent to provide better crop yield and meet the increasing demand for food and feed. GM crops have evolved to include a thorough safety evaluation for their use in human food and animal feed. Safety considerations begin at the level of DNA whereby the inserted GM DNA is evaluated for its content, position and stability once placed into the crop genome. The safety of the proteins coded by the inserted DNA and potential effects on the crop are considered, and the purpose is to ensure that the transgenic novel proteins are safe from a toxicity, allergy, and environmental perspective. In addition, the grain that provides the processed food or animal feed is also tested to evaluate its nutritional content and identify unintended effects to the plant composition when warranted. To provide a platform for the safety assessment, the GM crop is compared to non-GM comparators in what is typically referred to as composition equivalence testing. New technologies, such as mass spectrometry and well-designed antibody-based methods, allow better analytical measurements of crop composition, including endogenous allergens. Many of the analytical methods and their intended uses are based on regulatory guidance documents, some of which are outlined in globally recognized documents such as Codex Alimentarius. In certain cases, animal models are recommended by some regulatory agencies in specific countries, but there is typically no hypothesis or justification of their use in testing the safety of GM crops. The quality and standardization of testing methods can be supported, in some cases, by employing good laboratory practices (GLP) and is recognized in China as important to ensure quality data. Although the number of recommended, in some cases, required methods for safety testing are increasing in some regulatory agencies, it should be noted that GM crops registered to date have been shown to be comparable to their nontransgenic counterparts and safe . The crops upon which GM development are based are generally considered safe.
转基因作物于1995年首次引入农民,目的是提高作物产量,满足对粮食和饲料日益增长的需求。转基因作物已发展到对其用于人类食品和动物饲料进行全面的安全性评估。安全性考虑始于DNA层面,即对插入的转基因DNA一旦放入作物基因组后的含量、位置和稳定性进行评估。会考虑插入DNA编码的蛋白质的安全性及其对作物的潜在影响,目的是确保从毒性、过敏和环境角度来看,转基因新蛋白质是安全的。此外,提供加工食品或动物饲料的谷物也会进行测试,以评估其营养成分,并在必要时确定对植物成分的意外影响。为了提供安全评估的平台,通常在所谓的成分等效性测试中将转基因作物与非转基因对照物进行比较。新技术,如质谱分析和精心设计的基于抗体的方法,能够更好地分析作物成分,包括内源性过敏原。许多分析方法及其预期用途都基于监管指导文件,其中一些在全球认可的文件如《食品法典》中有所概述。在某些情况下,特定国家的一些监管机构会推荐动物模型,但通常没有关于其用于测试转基因作物安全性的假设或理由。在某些情况下,采用良好实验室规范(GLP)可以支持测试方法的质量和标准化,在中国,这被认为对确保数据质量很重要。尽管在某些情况下,一些监管机构推荐(在某些情况下是要求)的安全测试方法数量在增加,但应该指出,迄今为止注册的转基因作物已被证明与其非转基因对应物相当且安全。转基因作物所基于的作物通常被认为是安全的。